Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ROSIGLITAZONE MALEATE

ROSIGLITAZONE MALEATE

Standard Dose
2MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview ROSIGLITAZONE MALEATE is listed in Drugs@FDA under application 078825 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient ROSIGLITAZONE MALEATE Form and strength TABLET; ORAL - 2MG Sponsor MYLAN PHARMA Submission history Latest submission status date: 2008-12-02 00:00:00.

Structured Monograph

Clinical summary

Approval overview ROSIGLITAZONE MALEATE is listed in Drugs@FDA under application 078825 (ANDA). Marketing status: None (Tentative Approval) Active ingredient ROSIGLITAZONE MALEATE Form and strength TABLET; ORAL - 2MG Sponsor MYLAN PHARMA Submission history Latest submission status date: 2008-12-02 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.